REN - Redes Energéticas Nacionais SGPS S.A (RENE)
Euronext Lisbon · Portugal · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 3.535 |
|---|---|
| 52-week range | 3.090 – 3.950 |
| Return, 1 month / 3 months | −0.7% / −4.3% |
| Return, 1 year / 3 years | +19.0% / +73.4% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 17.0% |
| Worst drawdown (1 year) | -10.4% |
| Average daily value traded | 2.51M EUR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
REN - Redes Energéticas Nacionais SGPS is a Portuguese energy infrastructure company based in Lisbon. It operates the country's high-voltage electricity transmission network, moving power from generators to distribution grids and large consumers. It also runs the national natural gas transmission system and receives gas at the Sines terminal, and it manages the balancing and logistics of the gas system. Its customers are the electricity and gas market participants that use these regulated networks.
On this site REN - Redes Energéticas Nacionais SGPS S.A appears as a stock on the Euronext Lisbon (Portugal), code RENE, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
REN - Redes Energéticas Nacionais SGPS S.A (RENE) trades on the Euronext Lisbon in Portugal. It last closed at EUR 3.535 on 22 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 10 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.0% and over the last three months it fell 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -9.9% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.3% | ||
| 6-month return | -2.6% | ||
| 12-month return, skipping the last month | 19.8% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.4% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 2.51M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −0.7% |
| 3 months | −4.3% |
| 6 months | −2.6% |
| 1 year | +19.0% |
| 3 years | +73.4% |
| 5 years | +76.5% |
Signals
| 50-day / 200-day average | 3.531 / 3.574 |
|---|---|
| Golden / death cross (60 days) | Death, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.047 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | EUR 0.0960 |
| 19 Dec 2025 | EUR 0.0640 |
| 9 May 2025 | EUR 0.0930 |
| 18 Dec 2024 | EUR 0.0640 |
| 29 May 2024 | EUR 0.0900 |
| 21 Dec 2023 | EUR 0.0640 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.